The microRNA Expression Profiling in Heart Failure: A Systematic Review and Meta-Analysis

被引:19
作者
Shen, Nan-Nan [1 ]
Wang, Jia-Liang [1 ]
Fu, Yong-ping [2 ]
机构
[1] Shaoxing Univ, Dept Pharm, Affiliated Hosp, Shaoxing, Peoples R China
[2] Shaoxing Univ, Dept Cardiol, Affiliated Hosp, Shaoxing, Peoples R China
关键词
miRNAs; heart failure; systematic review; meta-analysis; biomarker; CIRCULATING MICRORNAS; SIGNALING PATHWAY; UP-REGULATION; BIOMARKER; SIGNATURES; IDENTIFICATION; PROGRESSION; IMPROVES; THERAPY; TARGET;
D O I
10.3389/fcvm.2022.856358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heart failure (HF) is a main consequence of cardiovascular diseases worldwide. Abnormal expression levels of microRNAs (miRNAs) in HF are observed in current studies. Novel biomarkers miRNAs may play an important role in the development of HF. Nevertheless, the inconsistency of miRNA expression limits the clinical application. We thus perform this systematic review of the miRNAs expression profiling to identify potential HF biomarkers. Methods: The electronic databases of Embase, Medline, and Cochrane Library were systematically searched to identify the miRNA expression profiles between HF subjects and non-HF controls before May 26th, 2021. The pooled results were shown as log10 odds ratios (logORs) with 95% confidence intervals (CI) using random-effect models. Subgroup analyses were conducted according to species, region, and sample source. The quality assessment of included studies was independently conducted based on Diagnostic Accuracy Study 2 (QUADAS-2). The sensitivity analysis was conducted based on sample size. Results: A total of 55 miRNA expression articles reporting 276 miRNAs of HF were included. 47 consistently up-regulated and 10 down-regulated miRNAs were identified in the overall analysis, with the most up-regulated miR-21 (logOR 8.02; 95% CI: 6.76-9.27, P < 0.001) and the most down-regulated miR-30c (logOR 6.62; 95% CI: 3.04-10.20, P < 0.001). The subgroup analysis of sample source identified 35 up-regulated and 10 down-regulated miRNAs in blood sample, the most up-regulated and down-regulated miRNAs were miR-210-3p and miR-30c, respectively. In the region sub-groups, let-7i-5p and miR-129 were most up-regulated and down-regulated in Asian countries, while in non-Asian countries, let-7e-5p and miR-30c were the most dysregulated. It's worth noting that miR-622 was consistently up-regulated in both Asian and non-Asian countries. Sensitivity analysis showed that 46 out of 58 (79.31%) miRNAs were dysregulated. Conclusion: A total of 57 consistently dysregulated miRNAs related to HF were confirmed in this study. Seven dysregulated miRNAs (miR-21, miR-30c, miR-210-3p, let-7i-5p, miR-129, let-7e-5p, and miR-622) may be considered as potential non-invasive biomarkers for HF. However, further validation in larger-scale studies are needed to verify our conclusions.
引用
收藏
页数:11
相关论文
共 94 条
[61]   MiR-216a accelerates proliferation and fibrogenesis via targeting PTEN and SMAD7 in human cardiac fibroblasts [J].
Tao, Jinsong ;
Wang, Jingyi ;
Li, Chunyu ;
Wang, Weiwei ;
Yu, Hao ;
Liu, Jinhui ;
Kong, Xiangqing ;
Chen, Yan .
CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2019, 9 (06) :535-+
[62]   Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study [J].
Taubel, Jorg ;
Hauke, Wilfried ;
Rump, Steffen ;
Viereck, Janika ;
Batkai, Sandor ;
Poetzsch, Jenny ;
Rode, Laura ;
Weigt, Henning ;
Genschel, Celina ;
Lorch, Ulrike ;
Theek, Carmen ;
Levin, Arthur A. ;
Bauersachs, Johann ;
Solomon, Scott D. ;
Thum, Thomas .
EUROPEAN HEART JOURNAL, 2021, 42 (02) :178-188
[63]   Circulating microRNAs in obese and lean heart failure patients: A case-control study with computational target prediction analysis [J].
Thome, Juliana Gil ;
Mendoza, Mariana Recamonde ;
Cheuiche, Amanda Veiga ;
La Porta, Vanessa Laubert ;
Silvello, Daiane ;
dos Santos, Katia Goncalves ;
Andrades, Michael Everton ;
Clausell, Nadine ;
Rohde, Luis Eduardo ;
Biolo, Andreia .
GENE, 2015, 574 (01) :1-10
[64]   MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts [J].
Thum, Thomas ;
Gross, Carina ;
Fiedler, Jan ;
Fischer, Thomas ;
Kissler, Stephan ;
Bussen, Markus ;
Galuppo, Paolo ;
Just, Steffen ;
Rottbauer, Wolfgang ;
Frantz, Stefan ;
Castoldi, Mirco ;
Soutschek, Jurgen ;
Koteliansky, Victor ;
Rosenwald, Andreas ;
Basson, M. Albert ;
Licht, Jonathan D. ;
Pena, John T. R. ;
Rouhanifard, Sara H. ;
Muckenthaler, Martina U. ;
Tuschl, Thomas ;
Martin, Gail R. ;
Bauersachs, Johann ;
Engelhardt, Stefan .
NATURE, 2008, 456 (7224) :980-U83
[65]   Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure [J].
Tian, Changhai ;
Gao, Lie ;
Zimmerman, Matthew C. ;
Zucker, Irving H. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2018, 314 (05) :H928-H939
[66]   MiR423-5p As a Circulating Biomarker for Heart Failure [J].
Tijsen, Anke J. ;
Creemers, Esther E. ;
Moerland, Perry D. ;
de Windt, Leon J. ;
van der Wal, Allard C. ;
Kok, Wouter E. ;
Pinto, Yigal M. .
CIRCULATION RESEARCH, 2010, 106 (06) :1035-U63
[67]   Role of MicroRNAs in Cardiac Remodeling and Heart Failure [J].
Topkara, Veli K. ;
Mann, Douglas L. .
CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (02) :171-182
[68]   The Future of Heart Failure Diagnosis, Therapy, and Management [J].
Udelson, James E. ;
Stevenson, Lynne Warner .
CIRCULATION, 2016, 133 (25) :2671-2686
[69]   MicroRNAs put their signatures on the heart [J].
Van Rooij, Eva ;
Olson, Eric N. .
PHYSIOLOGICAL GENOMICS, 2007, 31 (03) :365-366
[70]   MicroRNAs in heart failure: from biomarker to target for therapy [J].
Vegter, Eline L. ;
van der Meer, Peter ;
de Windt, Leon J. ;
Pinto, Yigal M. ;
Voors, Adriaan A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (05) :457-468